SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-5968
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants ; volume:8 ; number:1 ; day:21 ; month:12 ; year:2022 ; pages:1-13 ; date:12.2022
Cell discovery ; 8, Heft 1 (21.12.2022), 1-13, 12.2022
- Creator
-
Wang, Junxiang
Li, Kaiyi
Mei, Xinyue
Cao, Jinpeng
Zhong, Jiaying
Huang, Peiyu
Luo, Qi
Li, Guichang
Wei, Rui
Zhong, Nanshan
Zhao, Zhuxiang
Wang, Zhongfang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41421-022-00501-3
- URN
-
urn:nbn:de:101:1-2023030321130648830063
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Junxiang
- Li, Kaiyi
- Mei, Xinyue
- Cao, Jinpeng
- Zhong, Jiaying
- Huang, Peiyu
- Luo, Qi
- Li, Guichang
- Wei, Rui
- Zhong, Nanshan
- Zhao, Zhuxiang
- Wang, Zhongfang
- SpringerLink (Online service)
Other Objects (12)
Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection